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Abstract
Background: Neurons in the dorsal spinal cord play important roles in nociception and pain.
These neurons receive input from peripheral sensory neurons and then transmit the signals to the
brain, as well as receive and integrate descending control signals from the brain. Many molecules
important for pain transmission have been demonstrated to be localized to the dorsal horn of the
spinal cord. Further understanding of the molecular interactions and signaling pathways in the
dorsal horn neurons will require a better knowledge of the molecular neuroanatomy in the dorsal
spinal cord.
Results: A large scale screening was conducted for genes with enriched expression in the dorsal
spinal cord using DNA microarray and quantitative real-time PCR. In addition to genes known to
be specifically expressed in the dorsal spinal cord, other neuropeptides, receptors, ion channels,
and signaling molecules were also found enriched in the dorsal spinal cord. In situ hybridization and
immunohistochemistry revealed the cellular expression of a subset of these genes. The regulation
of a subset of the genes was also studied in the spinal nerve ligation (SNL) neuropathic pain model.
In general, we found that the genes that are enriched in the dorsal spinal cord were not among
those found to be up-regulated in the spinal nerve ligation model of neuropathic pain. This study
also provides a level of validation of the use of DNA microarrays in conjunction with our novel
analysis algorithm (SAFER) for the identification of differences in gene expression.
Conclusion: This study identified molecules that are enriched in the dorsal horn of the spinal cord
and provided a molecular neuroanatomy in the spinal cord, which will aid in the understanding of
the molecular mechanisms important in nociception and pain.
Background
The dorsal horn of the spinal cord plays important roles
in sensory information processing. The dorsal horn con-
tains the neural circuitry conveying nociceptive informa-
tion, including pain and temperature, from the periphery
by the primary afferents [1–3]. Nociceptive afferent fibers
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terminate predominately in the dorsal horn of the spinal
cord. Activation of the nociceptors transmits afferent mes-
sages to the spinal cord dorsal horn through neurotrans-
mitters such as glutamate. Initial processing of nociceptive
information occurs in the spinal cord dorsal horn by exci-
tatory and inhibitory interneurons. The projecting neu-
rons, spinalthalamic tract cells, then convey primary
nociceptive information to higher centers, signaling local-
ization and encoding the character of the nociceptive in-
put. Other inputs related to the subjective components of
pain and related to motor and autonomic control are also
relayed to higher centers. The projection neurons of the
dorsal horn also activate the descending control system,
which in turn controls the gain of dorsal horn neurons ei-
ther through excitatory or inhibitory mechanisms. In this
manner, the initial nociceptive information may be fur-
ther modulated by signals descending from higher centers
[1–3].
The dorsal horn can be subdivided into six distinct lami-
nae on the basis of the cytological features of its resident
neurons [2,4]. Classes of primary afferent neurons that
convey distinct modalities terminate in distinct laminae
of the dorsal horn. Thus, there is a close correspondence
between the functional and anatomical organization of
the neurons in the dorsal horn of the spinal cord. Nocice-
ptive neurons are mostly located in the superficial dorsal
horn, in the marginal layer (lamina I) and in the substan-
tia gelatinosa (lamina II), and receive direct synaptic input
from Aδ  and C fibers. Laminae III and IV are located ven-
tral to the substantia gelatinosa and contain neurons that
receive monosynaptic input from Aβ  fibers. Lamina V pri-
marily contains wide-dynamic-range neurons that project
to the brain stem and to regions of the thalamus. These
neurons receive monosynaptic input from Aδ  and Aβ  fib-
ers. They also receive input from C-fibers, either directly
on their dendrites, or indirectly via interneurons. Many
neurons in lamina V also receive nociceptive input from
visceral structures. Neurons in lamina VI receive input
from large-diameter afferents from muscles and joints and
respond to nonnoxious manipulations of joints. These
neurons are thought not to contribute to the transmission
of nociceptive messages.
Consistent with the important role of the dorsal horn of
the spinal cord in pain transmission and modulation,
neurochemical studies have implicated an enriched ex-
pression of neurotransmitters, neuropeptides, ion chan-
nels, and receptors in these neurons, including substance
P, enkephalin, CGRP, somatostatin, and GABA. The mor-
phology of primary afferent central terminals, dorsal horn
neurons, and descending systems, together with their
chemical neuroanatomy, synaptic arrangements, trans-
mitter systems, and functional properties have been exten-
sively documented [1–5]. However, the molecular/
chemical neuroanatomy of the dorsal horn is a subject
that is constantly being revised and updated as improved
techniques reveal new insights into classical pathways or
substances that are localized in the spinal cord. In this
study, we performed a large-scale screening for genes that
are enriched in the dorsal spinal cord. In addition to mol-
ecules that are known to be highly expressed in the dorsal
spinal cord, we identified other neuropeptides, ion chan-
nels, and signaling molecules enriched in the dorsal spi-
nal cord. We then further characterized the cellular
localization of a subset of these genes in the spinal cord,
as well as the regulation of a subset of the genes in a neu-
ropathic pain model.
Results
Global identification of genes that are enriched in the dor-
sal spinal cord using DNA microarray analysis
In order to identify genes that are enriched in the dorsal
spinal cord, we took advantage of DNA microarray tech-
nology which is powerful in identifying regional-specific
gene expression. We screened globally for genes that are
expressed at higher levels in the dorsal spinal cord as com-
pared to the ventral spinal cord. A total of 9 rats were used
in this study. Dorsal spinal cord and ventral spinal cord
are separated by cutting through the central cannel. Dor-
sal spinal cord samples from 3 rats were pooled and ven-
tral spinal cord samples from the same 3 rats were pooled
to form each pair of samples. RNA was prepared from 3
such pairs of samples, each was analyzed by hybridization
with a Affymetrix chip RG-U34A, which contains 8799
probesets. Using the SAFER analysis approach (see meth-
ods), we compared gene expression between the dorsal
and ventral spinal cord samples using a paired t-test and
analysis of variance (ANOVA). Using a paired t-test we
found 31 probesets with p-value smaller than 0.05 and
greater than 2-fold higher expression in the dorsal spinal
cord (Table 1). An ANOVA analysis detected 30 of these
31 probesets along with 21 additional probesets that met
these criteria. We found evidence in the literature for en-
riched expression in the dorsal spinal cord of 23 genes
among the 51 genes detected by ANOVA (Table 1). In ad-
dition, we independently tested the expression of 7 genes
by QRT-PCR, 2 genes by in situ hybridization, and 2 genes
by immunohistochemistry. All but one of these genes
were confirmed to be enriched in the dorsal spinal cord.
Both paired t-test and ANOVA analysis detected genes that
are enriched in the dorsal spinal cord as revealed by inde-
pendent confirmation. As ANOVA analysis provides more
candidate genes, we chose to subsequently present the re-
sults based on ANOVA analysis.
The 51 genes that are expressed higher in the dorsal spinal
cord represent several functional categories including
neuropeptides, ion channels, receptor and signaling mol-
ecules, calcium/calmodulin binding proteins, transcrip-BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/11
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Table 1: Confirmation and comparison of ANOVA and paired t-test for microarray analysis.
Accession# Description D vs V Ratio Confirmation PANOVA Ppair Reference
K02248 Somatostatin 11.1 literature <0.05 <0.05 [21–24]
S49491 Proenkephalin 4.9 literature <0.05 <0.05 [25–28]
L09119 Neurogranin 4.1 literature <0.05 <0.05 [29]
AF058795 GABA b2 2.8 literature <0.05 <0.05 [30]
AB004267 CAMK I b2 2.7 literature <0.05 <0.05 [31]
M15880 NPY 2.4 literature <0.05 <0.05 [24,32]
X04139 PKC 2.3 literature <0.05 <0.05 [33][34]
M25890 Somatostatin 12.4 literature <0.05 <0.05 [21–24]
X56306 Protachykinin 6.5 literature <0.05 <0.05 [24,27,35]
M15191 Beta-tachykinin 5.0 literature <0.05 <0.05 [24,27,35]
X55812 Cannabinoid receptor 2.9 literature <0.05 <0.05 [36]
M16410 Neurokinin B 2.3 literature <0.05 <0.05 [35,37]
X62840 K channel Kv 3.1 2.2 literature <0.05 <0.05 [38]
S79730 Nociceptin 2.1 literature <0.05 <0.05 [39]
S39221 NMDA receptor NR1 2.5 literature <0.05 <0.05 [40]
X57573 GAD 2.9 literature <0.05 <0.05 [24,41,42][43]
AI102205 Vesicle associated calmodulin protein 4.6 Test confirmed <0.05 <0.05
D17764 Synuclein beta 2.2 Test confirmed <0.05 <0.05
AF023087 NGFI-A 2.2 Test confirmed <0.05 <0.05
D12573 Hippocalcin 2.2 Test confirmed <0.05 <0.05
AI639118 EST 2.5 Test confirmed <0.05 <0.05
X54249 Zinc finger protein 2.4 Test not 
confirmed
<0.05 <0.05
X67241 Guanine nucleotide releasing factor 2.2 Not tested <0.05 <0.05
L25633 Neuroendocrine-specific protein 2.0 Not tested <0.05 <0.05
D10666 Neural visinin-like protein 2.4 Not tested <0.05 <0.05
D90219 CNP 2.2 Not tested <0.05 <0.05
AF007758 Synuclein-1 2.0 Not tested <0.05 <0.05
U88958 Neuritin 2.0 Not tested <0.05 <0.05
E13644 Neurodap-1 2.0 Not tested <0.05 <0.05
AI639213 EST 3.1 Not tested <0.05 <0.05
AF041107 Tulip2 2.1 Not tested >=0.05 <0.05
AF019974 Chromogranin B 2.5 literature <0.05 >=0.05 [44][45]
D10392 Syntaxin 1A 2.4 literature <0.05 >=0.05 [46]
M93669 Secretogranin 2.4 literature <0.05 >=0.05 [44,47]
X62839 K-channel 3.1 2.3 literature <0.05 >=0.05 [38]
AA894330 CAMKII beta 2.2 literature <0.50 >=0.05 [31]
L09119 Neurogranin 2.1 literature <0.05 >=0.05 [29]
AA925248 Sodium channel SCN6A 10.0 literature <0.05 >=0.05 [48]
AF078779 4-repeat ion channel 6.9 Test confirmed <0.05 >=0.05
S80376 G alpha(olf) 2.6 Test confirmed <0.05 >=0.05
AI014091 MRG1 2.1 Not tested <0.05 >=0.05
AI639036 EST 11.3 Not tested <0.05 >=0.05
AI639062 EST 2.9 Not tested <0.05 >=0.05
AI639470 EST 2.8 Not tested <0.05 >=0.05
M20722 Proline rich protein 2.7 Not tested <0.05 >=0.05
AF034899 Olfactory receptor (SCR D-9) 2.3 Not tested <0.05 >=0.05
AF019043 Dynamin-like protein 2.2 Not tested <0.05 >=0.05
AF091834 NSF 2.2 Not tested <0.05 >=0.05
X67877 Resiniferatoxin-binding protein 2.1 Not tested <0.05 >=0.05
AF089839 N-ethylmaleimide sensitive factor 2.1 Not tested <0.50 >=0.05
AI072943 EST 2.1 Not tested <0.05 >=0.05
AA866291 EST 2.0 Not tested <0.05 >=0.05
Genes that show greater than 2-fold expression in the dorsal spinal cord versus ventral spinal cord with P < 0.05 are listed for each analysis 
method. The gene expression fold increase for each probeset was calculated as the ratio of means of gene expression index between dorsal and 
ventral spinal cord.BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/11
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tion factors, synaptic proteins, and others (Table 2).
Neuropeptide genes are among the category that have the
highest number of genes expressed specifically in the dor-
sal spinal cord. These include somatostatin, protachyki-
nin, beta-tachykinin, neuropeptide Y (NPY), neurokinin
B, and nociceptin. In addition, we also detected another
peptide, C-type natriuretic peptide (CNP), which is ex-
pressed at 2-fold higher levels in the dorsal spinal cord. A
number of ion channels were found to be expressed high-
er in the dorsal spinal cord, including, voltage-gated sodi-
um channel type VI (SCAN6A), a putative four repeat ion
channel, NMDA receptor NR1, and potassium channel
Kv3.1. A few G-protein coupled receptors such as cannab-
inoid receptor, GABA-B R2 receptor, and olfactory recep-
tor-like protein (SCRD-9), as well as molecules important
in signaling such as Galpha(olf), Guanine nucleotide re-
leasing factor, and CAM kinase I beta 2, CAM kinase II be-
ta, and PKC beta were also identified to be expressed more
in the dorsal spinal cord. We found that the dorsally en-
riched genes also include several members of the calcium
sensor protein family, such as vesicle associated calcium
calmodulin binding protein (CAMK IV homolog), PKCγ
substrate neurogranin, chromogranin, neurovisinin-like
protein, secretogranin, and hippocalcin. In addition, sev-
eral transcription factors and synaptic proteins were also
expressed higher in the dorsal spinal cord (Table 2).
Table 2: Genes that are enriched in the dorsal spinal cord based on microarray analysis.
Description Accession# D vs V ratio Description Accession# D vs V ratio
Neuropeptide Calcium calmodulin binding protein
Somatostatin** M25890 11.1–12.4 Vesicle associated calmodulin protein AI102205 4.60
Protachykinin X56306 6.45 Neurogranin** L09119 2.1–4.1
Beta-tachykinin M15191 5.02 Chromogranin B AF019974 2.49
Proenkephalin S49491 4.89 Neural visinin-like protein D10666 2.42
NPY M15880 2.44 Secretogranin M93669 2.35
Neurokinin B M16410 2.27 Hippocalcin D12573 2.16
Nociceptin S79730 2.10
CNP D90219 2.17 Others
Syntaxin 1A D10392 2.43
Channel Synuclein-1 AF007758 2.03
Sodium channel SCN6A AA925248 10.02 Synuclein beta D17764 2.21
Four repeat ion channel AF078779 6.92 Neuritin U88958 2.03
NMDA receptor NR1 S39221 2.48 Neurodap-1 E13644 2.03
K channel Kv 3.1** X62840 2.2–2.3 GAD X57573 2.86
Proline-rich protein M20722 2.73
Signaling NSF AF091834 2.16
Cannabinoid receptor X55812 2.93 Resiniferatoxin-binding protein X67877 2.13
GABA-B R2 AF058795 2.79 N-ethylmaleimide sensitive factor AF089839 2.08
Olfactory receptor (SCR D-9) AF034899 2.35 Tulip2 AF041107 2.08
G alpha (olf) S80376 2.63 Neuroendocrine-specific protein L25633 2.01
Guanine nucleotide releasing factor X67241 2.21 Dynamin-like protein AF019043 2.22
CAMK I beta 2 AB004267 2.73
CAMKII beta AA894330 2.15 EST
PKC beta X04139 2.29 EST AI639036 11.34
EST AI639213 3.13
Transcription factor EST AI639062 2.88
Zinc finger protein X54249 2.40 EST AI639470 2.77
NGFI-A AF023087 2.21 EST AI639118 2.50
MRG1 AI014091 2.12 EST AI072943 2.06
EST AA866291 2.01
Genes that show greater than 2-fold expression in the dorsal spinal cord versus ventral spinal cord with P < 0.05 are listed according to their broad 
functional categories. The gene expression fold increase for each probeset was calculated as the ratio of means of gene expression index between 
dorsal and ventral spinal cord. The genes shown to be up-regulated by more than one probeset are indicated with asterisks. The fold increase for 
these genes is given as a range of fold increase detected by all the probesets for that gene. The genes that were tested by real-time PCR or immu-
nohistochemistry are underlined.BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/11
Page 5 of 12
(page number not for citation purposes)
QRT-PCR confirmation of genes enriched in the dorsal spi-
nal cord
We sought to confirm the differential gene expression of a
selected subset of genes in the spinal cord along the dor-
sal-ventral axis using QRT-PCR. The genes selected
showed expression differences between 2 to 7-fold by
DNA microarray. We compared gene expression between
dorsal and ventral spinal cord samples. And the results of
these comparisons are depicted in Fig. 1. In general, high-
er expression was confirmed for 6 out of the 7 genes tested
in the dorsal spinal cord, despite some degree of variation
among the 3 pairs of samples from different animals (Fig.
1).
We confirmed the enriched expression of the following
genes: a transcription factor NGFI-A, a putative four repeat
ion channel, a vesicle associated calcium/calmodulin
binding protein that is homologous to CAMK IV, a neuro-
nal calcium sensor protein hippocalcin, synuclein beta,
and an EST gene. The Zinc finger protein mRNA was
found to be only marginally enriched in the dorsal spinal
cord (Fig. 1).
Figure 1
Differential expression of genes in the dorsal versus ventral spinal cord as revealed by QRT-PCR. The ratio of
expression between dorsal and ventral spinal cord for each gene in each dorsal and ventral spinal cord sample pair is shown.
Data were from QRT-PCR assays performed in triplicate for a pair of RNA samples, each of which was pooled from the dorsal
or ventral samples of the 3 pairs of RNA samples used for microarray analysis (from a total of 9 animals). The length of bars
represent 95% confidence intervals and the symbol on each bar is the mean of ratios estimated from the assay performed in
triplicate.BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/11
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Cellular expression of dorsal spinal cord-enriched genes
Using in situ hybridization and immunohistochemistry,
we sought to investigate whether differences in gene ex-
pression as detected by DNA microarray reflect differences
at the cellular level. In situ hybridization revealed that
PKCγ  substrate neurogranin and vesicle-associated calci-
um/calmodulin binding protein (CAMK IV homolog)
mRNA are both highly enriched in the superficial layers of
the dorsal horn of the spinal cord (Fig. 2). Neurogranin
expression seems to be enriched in subsets of the cells of
lamina II and III (Fig. 2A), similar to PKCγ  localization
(Fig 3C). CAMK IV homolog seems to be broadly ex-
Figure 2
mRNA localization of neurogranin and CAMK IV homolog. Neurogranin (A) and CAMK IV homolog (B) are located in
the superficial dorsal horn and exhibit different patterns with the antisense riboprobes. Pictures were pieced together from 4
images which were taken using 4X objectives.BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/11
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pressed in layers I-III of the dorsal horn (Fig. 2B). Immu-
nohistochemistry with antibodies against Galpha(olf),
syntaxin 1A, and PKCγ  revealed that these proteins are
also enriched in the dorsal spinal cord (Fig. 3). Gal-
pha(olf) and Syntaxin 1A appear to be localized in the
neuropil of the dorsal horn (Fig. 3A and 3B) whereas,
PKCγ  appears to be expressed in layer IIi of the dorsal
horn (Fig. 3C) as previously described [6].
Regulation of dorsally enriched genes in a chronic neuro-
pathic pain model
We sought to study whether the genes that are enriched in
the dorsal spinal cord are regulated during a persistent
pain state such as the spinal nerve ligation (SNL) model
of neuropathic pain. For a subset of genes enriched in the
dorsal spinal cord, we used QRT-PCR to compare the gene
expression in the lumbar spinal cord between spinal nerve
ligation rats and rats subjected to sham surgery, and to
compare expression between ipsilateral and contralateral
sides (separated by cutting through the midline in the seg-
ment of lumbar spinal cord) in spinal nerve ligation rats.
In general, we found that genes that are enriched in the
dorsal spinal cord are not among those found to be up-
regulated in the spinal nerve ligation model of neuropath-
ic pain (Table 3).
Discussion
The dorsal spinal cord is a region implicated in sensory
perception, receiving, transmitting, and modulation of
signals from peripheral sensory system. It is important in
the integration of computational and neuromodulatory
functions. In a pathological state, the changes in the dor-
sal horn of the spinal cord may contribute to prolonged
abnormal pain. The aim of this study was to find genes
that are enriched in the dorsal spinal cord that can poten-
tially play important roles in pain transmission, pain
modulation, and pathophysiological conditions. Since
microarray technology represents a potentially powerful
method for identifying cell type- and regionally restricted
genes expressed in the nervous system [7,8], we conducted
a large-scale screening using this technique for genes that
are expressed higher in the dorsal spinal cord. Genes
found in this screen can then be further studied for their
cellular localization in the spinal cord.
Validation of microarray data
The reliability of these DNA microarray results is demon-
strated by the following three observations: (1) A subset of
the genes was observed to be consistently regulated by
multiple probesets on the microarray; (2) We detected 21
genes (by 23 probesets) which have previously been de-
scribed to be enriched in the dorsal spinal cord; (3) Genes
that we chose to study further were confirmed to be ex-
pressed higher in the dorsal spinal cord by QRT-PCR (6
out of 7), in situ hybridization (2 out of 2), and immuno-
histochemistry (2 out of 2). Based on the consistency and
the rate of independent confirmation, many of the genes
listed in the tables are likely to be true positives.
Figure 3
Cellular localization in the spinal cord as revealed by immunohistochemistry. Galpha(olf) (A), Syntaxin 1A (B), and
PKCγ  (C) are localized primarily in the dorsal spinal cord. Images were taken from sections of spinal cord from the same ani-
mal although similar patterns of staining were found when two animals were examined.BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/11
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We note that our list of dorsal spinal cord-enriched genes
is likely to be incomplete since the Affymetrx DNA micro-
arrays do not represent the entire rat genome and our
study may not have been sensitive enough to discover all
the genes, especially those that are expressed at low levels.
Toward a molecular anatomy of the spinal cord, particu-
larly in the pain sensory pathways
We found that some genes are expressed in a lamina-spe-
cific manner, while others may have a gradient of expres-
sion. Neurogranin is highly enriched in the superficial
laminae. PKCγ  has been demonstrated to be expressed in
lamina IIi. The colocalization of neurogranin and PKCγ  in
similar regions in the spinal cord suggests that neuro-
granin may be an endogenous substrate of PKCγ  in the
spinal cord. Neurogranin has been shown to be phospho-
rylated by PKCγ , and this phosphorylation is greatly de-
creased in PKCγ  knockout mice, suggesting neurogranin is
a PKCγ -specific substrate [9]. Evidence that strongly sug-
gests the phosphorylation of neurogranin plays an impor-
tant role in neural plasticity comes from the studies that
demonstrated neurogranin knockout mice show essen-
tially the same deficits in behaviors related to learning and
memory as that of the PKCγ  knockout mice [10]. Neuro-
granin is not only a substrate of PKCγ , but also plays a im-
portant role in regulating PKC signaling [11]. Interstingly,
PKCγ  knockout mice demonstrate reduced neuropathic
pain [12]. Similar to neurogranin, we found that a cal-
modulin-binding, vesicle-associated, CAM kinase IV-like
protein is highly expressed and enriched in the superficial
layer of the dorsal spinal cord. The function of this gene is
not yet known. However, the protein was also found to be
enriched in forebrain neurites [13].
Using immunostaining, we found that Syntaxin 1A and
Galpha(olf) proteins were enriched in the dorsal spinal
cord. Syntaxin 1A has previously been shown to be prefer-
entially expressed in the dorsal spinal cord neuropil. Gal-
pha(olf) is a G protein that was initially found to be
expressed in the olfactory epithelium. The Galpha(olf)
has been shown to be specifically expressed in the stria-
tum in the brain and was found to colocalize with and ac-
tivated by adenosine A2A receptors [14]. It is possible that
the specific expression of Galpha(olf) in the dorsal spinal
cord implies its mediation of functions for specific G-pro-
tein-coupled receptors in these neurons.
Conclusions
1. We conducted a large-scale screening using DNA micro-
array for genes that are specifically expressed in the dorsal
spinal cord. We found additional neuropeptides, recep-
tors, ion channels, and signaling molecules to be enriched
in the dorsal spinal cord.
2. The regulation of a subset of the genes was confirmed
by QRT-PCR. Six out of the seven genes were confirmed to
be enriched in the dorsal spinal cord.
3. In situ hybridization and immunohistochemistry re-
vealed that neurogranin, CAMK IV homolog, Galpha(olf),
and Syntaxin 1A, are indeed enriched in the dorsal spinal
cord.
4. Through the detection of a large number of genes which
were previously determined to have enriched expression
in the dorsal spinal cord and our QRT-PCR, in situ hybrid-
ization and immunohistochemical confirmations, this
study provides a level of validation for the case of Affyme-
Table 3: Relative gene expression in the spinal cord of SNL (Chung) neuropathic pain model as revealed by QRT-PCR.
Chung Ipsilateral vs Contralateral Chung Ipsilateral vs Sham ipsilateral
Relative Expression Scale Relative Expression Scale
Estimate Lower 95% CI Upper 95% CI Estimate Lower 95% CI Upper 95% CI
NGFI-A 1.211 0.887 1.654 1.217 0.959 1.544
4 Repeat Ion Channel 0.837 0.613 1.143 1.197 0.944 1.519
CAMK IV Homolog 0.968 0.709 1.322 1.206 0.950 1.530
EST (AI639118) 0.831 0.609 1.135 0.859 0.677 1.089
Hippocalcin 1.089 0.798 1.487 1.237 0.975 1.569
Synuclein beta 1.079 0.791 1.473 1.278 1.007 1.621
Neurogranin 0.897 0.501 1.606 0.977 0.562 1.698
The expression between Chung ipsilateral and contralateral spinal cord, as well as between Chung ipsilateral spinal cord and sham ipsilateral spinal 
cord were compared and fold changes estimated with 95% confidence interval given.BMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/11
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trix DNA microarrays in conjunction with SAFER algo-
rithm to detect differences in gene regulation.
Materials and Methods
Animals
Male Sprague-Dawley rats (Taconic, Germantown, NY.)
weighing 200–300 g at the time of testing, were main-
tained in a climate-controlled room on a 12 h light/dark
cycle (lights on at 06:00) with food and water available ad
libitum. All of the handling of the animals and testing was
performed in accordance with the policies and recom-
mendations of the International Association for the Study
of Pain [15] and received approval from the Institutional
Animal Care and Use Committee of MRL, West Point, PA.
Spinal nerve ligation (SNL) injury was induced using the
procedure of Kim and Chung [16]. Anesthesia was in-
duced with 2% gaseous isofluorane (For induction 3–5%
and O2 500–700 µl, for maintenance 2–3% and O2 400–
500 µl). Following dorsal skin incision and muscle sepa-
ration, the posterior interarticular transverse process of L/
S1 was exposed and carefully removed with a micro
Rongeur. The L5 and L6 spinal nerves were tightly ligated
by a square knot with 6–0 silk thread. The muscles were
closed with 4–0 absorbable sutures and the skin was
closed with wound clips. Rats that exhibited motor defi-
ciency (such as paw dragging) or failure to exhibit subse-
quent tactile allodynia were excluded from further testing
(less than 5% of the animals were excluded). Sham con-
trol rats underwent the same operation and handling as
the experimental animals but without spinal nerve liga-
tion.
Behavioral testing
The assessment of tactile allodynia (i.e. decreased thresh-
old to paw withdrawal following probing with non-nox-
ious mechanical stimuli) consisted of measuring the
withdrawal threshold of the paw ipsilateral to the site of
nerve injury in response to probing with a series of cali-
brated von Frey filaments. Each filament was applied per-
pendicularly to the plantar surface of the ligated paw of
rats kept in suspended wire-mesh cages. The withdrawal
threshold was determined by sequentially increasing and
decreasing the stimulus strength ("up-down" method),
analyzed with a Dixon non-parametric test [17] and ex-
pressed as the mean withdrawal threshold. Animals were
tested before surgery and only animals with a paw with-
drawal threshold greater than 10 grams were used for the
subsequent study. Surgically treated animals were then
tested on postoperative days 3 and 12. Only those animals
that showed allodynia (paw withdrawal threshold smaller
than 3 g) on both days were used for tissue collection on
postoperative day 13 (less then 10% of the animals were
excluded for tissue collection).
Tissue dissection and RNA preparation
Total RNA from each sample was prepared using Trizol™
(Life Technologies, Gaithersburg, MD), followed by RNE-
asy™ (Qiagen, Hilden Germany). RNA samples were ana-
lyzed by denatured gel electrophoresis. In addition, total
RNA quality was assessed by capillary electrophoresis (Bi-
oanalyzer 2100 Agilent, Palo Alto, CA) to ensure that the
28S:18S rRNA ratio was >1.0 for each sample.
Affymetrix microarray hybridization and staining
Hybridization probes were prepared according to Affyme-
trix instruction [18]. 5 µM primer encoding the T7 RNA
polymerase promoter linked to oligo-dT24 primer was
used to prime double-stranded cDNA synthesis from each
total RNA sample (25 µg). cDNA synthesis reactions were
carried out at 42°C using Superscript II RNAseH- reverse
transcriptase (Life Technologies, Rockville MD). Second
strand cDNA synthesis was finished using DNA polymer-
ase I and T4 DNA ligase. Each double-stranded cDNA
sample was purified by sequential phenol/chloroform ex-
traction (Ambion, Austin, TX) and adsorption to silica
(Qiaquick™ kit, Qiagen, Hilden, Germany) according to
manufacturers' instructions. Half of each cDNA sample
was transcribed in vitro into the copy RNA (cRNA) labeled
with biotin-UTP and biotin-CTP using the BioArray High
Yield RNA Transcript Labeling Kit (Enzo Biochemicals,
New York, NY). These cRNA transcripts were purified us-
ing RNeasy™ columns (Qiagen, Hilden Germany) and
quantitated by measuring absorption at 260 nm/280 nm.
15 µg aliquots of each cRNA sample were fragmented at
95°C for 35 min in 40 mM Tris-acetate, pH8.0, 100 mM
KOAc, and 30 mM MgOAc to a mean size of ~50–150 nu-
cleotides. Hybridization buffer (0.1 M MES, pH6.7, 1 M
NaCl, 0.01% Triton, 0.5 mg/ml BSA, 0.1 mg/ml H. Sperm
DNA, 50 pM Control Oligo B2, and 1X Eukaryotic hybrid-
ization Control) was added to each sample. Samples were
then hybridized to RG-U34A microarrays (Affymetrix) at
45°C for 16 h. Microarrays were washed and sequentially
incubated with streptavidin phycoerythrin (Molecular
Probes, Eugene, OR), biotinylated anti-streptavidin anti-
body (Vector Laboratories, Inc., Burlingame, CA), and
streptavidin phycoerythrin on the Fluidic Station (Af-
fymetrix, Santa Clara, CA). Finally, the microarrays were
scanned with a dedicated Gene Array Scanner (Hewlett
Packard Instruments, TX) to capture a fluorescence image.
Affymetrix microarray data analysis
A total of 9 animals was divided into 3 groups, and the
dorsal and ventral spinal cord were pooled for each group
to give rise to 6 samples. Each sample was analyzed on
one Affymetrix microarray RG-U34A. For each probeset
(an array of 16 pairs of oligonucleotides for a specific
gene) an index of gene expression was calculated and an-
alyzed using the SAFER algorithm [19] for all chip analy-
sis. The SAFER gene expression index is a robust andBMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/11
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resistant measure of gene expression which is an alterna-
tive to the 'average difference' calculated by the Affymetrix
analysis software and the model-based expression index
proposed by Li and Wong [20]. Like Li and Wong's proce-
dure, the procedure for calculating the SAFER gene index
involves both between-array normalization and an adjust-
ment for probe-specific biases.
To analyze gene expression in the spinal cord, differences
in mean level of the gene expression index between dorsal
and ventral samples were assessed for each probeset using
a paired t-test and ANOVA. These models facilitated esti-
mation of ratios comparing the dorsal and ventral sam-
ples and calculation of p-values testing whether the ratios
are different from one (i.e. a ratio of one implies no
change between the means for the experimental condi-
tions). By fitting separate models for each probeset, differ-
ences were assessed using an error term that included
biological variability between samples and did not as-
sume that this variability was the same for all genes.
Quantitative Real-Time PCR (QRT-PCR)
Total RNA was treated with DNase I, Amplification Grade
(Invitrogen, Carlsbad, CA) to remove DNA contamina-
tion before cDNA synthesis. cDNA was synthesized with
oligo (dT)12–18 using Superscript First-Strand Synthesis
System for RT-PCR (Invitrogen, Carlsbad, CA). Real-time
PCR analysis was performed on a Applied Biosystems ABI
Prism7700 Sequence Detection System. Matching primers
and fluorescence probes were designed for each of the
genes using the Primer Express program provided by Ap-
plied Biosystems. Both forward and reverse primers were
used at 900 nM. In all cases, the final probe concentration
was 250 nM. The PCR reaction was performed in a final
volume of 50 µl using TaqMan Universal PCR Master Mix
containing AmpliTaq GoldR DNA Polymerase, AmpEras-
eR UNG, dNTPs (with dUTP), Passive Reference 1, opti-
mized buffer components (proprietary formulation) and
1 µl of cDNA template.
Primers and probes for GAPDH and IL-18 were obtained
from Applied Biosystems. The sequence of the primers
and probes used is listed in Table 4.
QRT-PCR Data Analysis
Average Ct values from triplicate PCR reactions were nor-
malized to average Ct values for GAPDH RNA from the
same cDNA preparations. The ratio of expression of each
gene between dorsal and ventral samples was calculated
as: 2-(mean∆∆ Ct).  Ct represents the threshold cycle and
∆∆ Ct represents the difference Ct(test gene) - Ct(GAPDH RNA)
for dorsal sample minus ventral sample. Using the ANO-
VA method, 95% confidence intervals were determined
for each ratio as:
Table 4: Primers and probes used for QRT-PCR. The sequences of forward, reverse and specific probes are listed sequentially for each 
gene (accession #).
Gene (GenBank accession #) Bases Sequence (5'-3') Product size (bp)
NGFI-A (AF023087) 120–140 TATCCATGTTCGGGAGTTGGA 81
171–200 AATGAACTTCATGTTCATAGCATACAAAGT
142–170 CACCGCCTACTCAGTAGGTAACCACAGCA
Four Repeat Ion Channel (AF078779) 5127–5150 GGAGGAAGGACAACAATGAAGTCT 75
5183–5201 TTCGGAGCCACAGGAAGCT
5155–5177 TGTGCAAGATGAACCCCATGCCA
CAMK IV homolog (AI102205) 263–283 TGTGAAAAGCAAGCTCCCAAA 81
323–343 CAGGCTCAGGCCATAAATCCT
299–319 CTGCCATGCCTCCCTGGGAGG
EST (AI639118) 56–80 GAAGTTGCTCTGACTGAATGGATTT 123
153–178 TCACAGACTTACATCCTGTTTCTGAA
93–121 AGCTGTCACACTTGTTGTCGGAAGCACAC
Hippocalcin (D12573) 607–628 CCGGAAAAGAGGACTGAGAAAA 134
723–740 CTGCTGGGATCGCATTGC
630–656 CTTCCGCCAAATGGACACAAACAATGA
Synuclein beta (D17764) 227–247 AACAAAGGAGCAGGCATCTCA 127
336–353 TTGGGCCACTTCCTCTGG
274–296 CTGGGAACATTGCAGCAGCCACC
Zinc Finger Protein (X54249) 1870–1893 GAGAGTGCACACATCAGCATTAGA 98
1944–1967 TCCTTTTCACCATCGTGTAAGTCA
1918–1941 CAGCTCTGTACCTCAGCCGCCCACBMC Neuroscience 2002, 3 http://www.biomedcentral.com/1471-2202/3/11
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where t0.975 is the 97.5th percentile of the t-distribution
with N-m degrees of freedom, N is the total pooled sam-
ple size for a gene, m is the number of treatments includ-
ing control, s is the pooled standard deviation, ni and nj
are the number of dorsal and ventral samples, respective-
ly, being compared. Similarly, expression between ipsilat-
eral and contralateral samples were analyzed.
Immunocytochemistry
Rat spinal cords were dissected from rats which had been
perfused with 4% paraformaldehyde and post fixed for 4
hours. After cryoprotection in 30% sucrose overnight and
30% sucrose/OCT (1:1) mixture for 8 hours, the tissue
was frozen and sections of 30 um were cut with cryostat.
Tissue sections were floated, washed several times with
PBS, then treated with 0.5% H2O2 for 30 minutes fol-
lowed by washing with PBS 3 times. The sections were
then incubated with blocking buffer (3% BSA + 3% don-
key serum + 0.1% Triton) for 1 hour, followed by incuba-
tion with primary antibodies for 2 hours at room
temperature. After washing with PBS 10 times, the sec-
tions were incubated with secondary antibodies, AB en-
zyme reagent (ABC kit, Vector) and developed using a
Vector DAB staining Kit according to manufacturer's rec-
ommendations. The antibody to syntaxin-1 and Gal-
pha(olf) were purchased from Santa Cruz Biotechnology,
Inc. and used at 1: 20 dilution.
In situ hybridization
Twenty micron sections were collected on gelatin-coated
slides, dried and then stored at -80°C in desiccated boxes.
At the time of processing, the slides were warmed to room
temperature, postfixed in paraformaldehyde, treated with
acetic anhydride and then delipidated and dehydrated.
Processed section-mounted slides were hybridized with
antisense or sense (control) riboprobes (8–12 ×  106
DPM/slide) in 50% formamide hybridization mix and in-
cubated overnight at 55°C in an open-air humidified slide
chamber. In the morning, the slides were immersed in 2 ×
SSC (0.3 M NaCl, 0.03 M sodium citrate; pH 7.0)/10 mM
DTT, treated with RNase A (20 mg/ml) and washed 2 ×  30
min at 65°C in 0.1×  SSC to remove nonspecific label. After
dehydration, the slides were apposed to BioMax (BMR-1;
Kodak) X-ray film for 1–2 days and then dipped in NTB2
nuclear emulsion (Eastman Kodak; diluted 1:1 with 600
mM ammonium acetate). The slides were exposed for 21
days in light-tight black desiccated boxes, photographical-
ly processed, stained in Cresyl violet and coversliped.
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